Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab

Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab

Bibliographic Details
Main Authors:	Reem Kashlan, MPH, Kristin Slater, MS, Martin E. Garber, DO, Francisca Kartono, DO
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	JAAD Case Reports
Subjects:	biologics brodalumab guselkumab paradoxical reaction psoriasis psoriatic arthritis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621000461

Similar Items

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
by: Pinter A, et al.
Published: (2019-07-01)

Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
by: Roman M, et al.
Published: (2017-07-01)

The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infection
by: Eingun James Song, MD, FAAD, et al.
Published: (2021-02-01)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
by: Light JG, et al.
Published: (2021-01-01)

Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
by: Galluzzo M, et al.
Published: (2019-05-01)

Effectiveness of IL-23 Inhibitor Guselkumab in Real-World Chinese Patients with Psoriasis During a 20-Week Period
by: Chan Y, et al.
Published: (2021-06-01)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
by: Yang EJ, et al.
Published: (2019-06-01)

Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry
by: Callis Duffin, K., et al.
Published: (2022)

Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade
by: V. V. Chikin
Published: (2020-01-01)

Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study
by: Marco Galluzzo, et al.
Published: (2020-07-01)

Rapid resolution of pyoderma gangrenosum with brodalumab therapy
by: Michael W. Tee, MD, et al.
Published: (2020-11-01)

Injection-Site Reaction to Brodalumab in a Psoriasis Patient: Report of Clinicopathological Findings
by: Huang, I.-H, et al.
Published: (2022)

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
by: Nicole L. Bolick, et al.
Published: (2020-12-01)

Interleukin 17 deficiency and implications in cutaneous and systemic diseases
by: Elizabeth Z. Welch, et al.
Published: (2015-07-01)

Treatment of refractory dissecting cellulitis of the scalp with guselkumab: Case report
by: Sonal Muzumdar, et al.
Published: (2020-01-01)

Brodalumab in psoriasis: evidence to date and clinical potential
by: Amy C Foulkes, et al.
Published: (2019-04-01)

Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum
by: Cassandra Baier, MS, PA-C, et al.
Published: (2021-02-01)

Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
by: Astrid‐Helene Ravn Jørgensen, et al.
Published: (2020-12-01)

ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
by: Tatyana G. Sidorcika, et al.
Published: (2018-04-01)

Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study
by: Yuliya Lytvyn, PhD, et al.
Published: (2021-09-01)

Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies
by: N. N. Potekaev, et al.
Published: (2020-10-01)

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy
by: Sara Al-Khawaga, MD, et al.
Published: (2021-10-01)

Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus
by: Wimolsiri Iamsumang, et al.
Published: (2017-03-01)

Metabolomics Studies in Psoriatic Disease: A Review
by: John Koussiouris, et al.
Published: (2021-06-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
by: A. A. Barilo, et al.
Published: (2019-01-01)

REVISITING THE DIAGNOSIS OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS
by: E. S. Yakubovskaya
Published: (2016-02-01)

COMORBIDITIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: Zhdan V. M., et al.
Published: (2020-12-01)

Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
by: Ganesh Pai, et al.
Published: (2017-08-01)

Analysis of a real practice in hospital pharmacotherapy psoriatic arthritis
by: Levitan A.l., et al.
Published: (2016-09-01)

Prevalence of Psoriatic Arthritis among Psoriatic Patients in Damietta Governorate
by: Aisha Mohamed, et al.
Published: (2019-10-01)

Nail manifestations in Hong Kong Chinese patients with psoriatic arthropathy (PsA)
by: Lai Tin Lok
Published: (2016-12-01)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: S. V. Smirnova, et al.
Published: (2014-08-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

MANUBRIOSTERNAL JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS
by: Hassan Iffat, et al.
Published: (2011-04-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Clinical and laboratory characteristics of psoriatic arthritis in a cohort of Egyptian patients
by: Dalia A. ElSherbiny, et al.
Published: (2021-06-01)

Off-label Use of Tocilizumab in Psoriatic Arthritis: Case Series and Review of the Literature
by: Pedro Madureira, et al.
Published: (2016-07-01)

Prevalence and severity of fatigue in psoriasis and psoriatic arthritis
by: Magdalena Krajewska-Włodarczyk, et al.
Published: (2020-03-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

Cannot write session to /tmp/vufind_sessions/sess_c7ttqte2nvh7pdv3r2agnj6mrs